111 (YI) Preferred Stock Liabilities (2017)

111's (YI) quarterly Preferred Stock Liabilities came in at $227.8 million in Q4 2017.

111 (YI) Preferred Stock Liabilities (2017) Analysis & Trends

111 has disclosed Preferred Stock Liabilities across 1 years of filings, most recently posting $227.8 million for Q4 2017.

Preferred Stock Liabilities for Q4 2017 came in at $227.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was $227.8 million (changed N/A YoY), and the FY2017 annual result was $223.0 million, changed N/A from the prior year.
Preferred Stock Liabilities came in at $227.8 million for Q4 2017 at 111.
In the past five years, Preferred Stock Liabilities ranged from a high of $227.8 million in Q4 2017 to a low of $227.8 million in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Stock Liabilities (Qtr)
1	Akso Health	2,315,158.81 Bn	2,315,158.63 Bn	-	256,330.00
2	Mckesson	92.76 Bn	89.18 Bn	4.04 Bn	-
3	Cencora	52.82 Bn	50.83 Bn	3.59 Bn	-
4	Cardinal Health	52.17 Bn	48.39 Bn	2.50 Bn	-
5	Henry Schein	9.19 Bn	9.71 Bn	1.07 Bn	-
6	Accendra Health	246.88 Mn	-90.00 Mn	312.39 Mn	-
7	Edap Tms	161.92 Mn	146.92 Mn	8.15 Mn	-
8	111	107.47 Mn	25.61 Mn	23.58 Mn	-
9	Cosmos Health	9.42 Mn	7.26 Mn	1.38 Mn	-
10	Cellyan Biotechnology	5.69	-2.48 Mn	-	-

Download Data

Date	Value
Dec 31, 2017	227.76 Mn